RxDoctor Payments Data

Hatice Hasturk

Periodontics · Boston, MANPI 1518284686

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,600 of the $1,694 with a category attached, or 94.4%. GSK accounts for 94.4% of it on its own, with 2 other manufacturers making up the rest.

$1,694in general payments, 2019–2025

Across 4 payments — averaging $423.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$2K
  • Geistlich Pharma, North America, Inc.$81
  • Zimvie Inc.$13
$787,808in research payments, 2019–2025

Across 9 payments — averaging $87,534 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$358K
  • GSK$224K
  • Sanofi US Services Inc.$205K

What the payments were for

  • Consulting fees$1,60094%
  • Food & beverage$946%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK2$1,600
Geistlich Pharma, North America, Inc.1$81
Zimvie Inc.1$13

How this compares

$1,694 in reported general payments places this provider in the 80th percentile of 243 periodontics providers in Massachusetts.

See all periodontics providers in Massachusetts →

Other periodontics in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →